Physiogenex offers various tools to evaluate your drugs targeting metabolic disorders. Our technical platform allows for a wide range of analysis which will depend on your choice of models and study type. Our CRO capacity provides you with accurate, reliable data to progress in the development of your drug candidate.
In vivo studies
Ex vivo screening
The studies we can run:
- Acute, sub-chronic or chronic efficacy pharmacology studies,
- Drug activity and mechanisms of action in specific in vivo models,
- Evaluation of adverse effects and/or additional benefits, tissue by tissue,
- Studies of drug combinations.
CONTACT US FOR MORE INFORMATION